Springworks Therapeutics Stock Price on March 17, 2023
| SWTX Stock | USD 41.48 0.25 0.60% |
Below is the normalized historical share price chart for SpringWorks Therapeutics extending back to September 13, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of SpringWorks Therapeutics stands at 41.48, as last reported on the 30th of November, with the highest price reaching 41.85 and the lowest price hitting 40.85 during the day.
If you're considering investing in SpringWorks Stock, it is important to understand the factors that can impact its price. At this stage we consider SpringWorks Stock to be very steady. SpringWorks Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0286, which indicates the firm had a 0.0286% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for SpringWorks Therapeutics, which you can use to evaluate the volatility of the company. Please validate SpringWorks Therapeutics' Coefficient Of Variation of 5649.19, risk adjusted performance of 0.0209, and Semi Deviation of 2.66 to confirm if the risk estimate we provide is consistent with the expected return of 0.0839%.
At this time, SpringWorks Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock is likely to rise to about 13.2 K in 2024, whereas Treasury Stock is likely to drop (792.9 K) in 2024. . At this time, SpringWorks Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 3.86 in 2024, whereas Price Earnings Ratio is likely to drop (7.44) in 2024. SpringWorks Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of June 1987 | 200 Day MA 39.8523 | 50 Day MA 32.9203 | Beta 0.792 |
SpringWorks |
Sharpe Ratio = 0.0286
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | SWTX | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.94 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average SpringWorks Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SpringWorks Therapeutics by adding it to a well-diversified portfolio.
Price Book 5.8285 | Enterprise Value Ebitda (7.90) | Price Sales 22.7738 | Shares Float 72.9 M | Wall Street Target Price 67.3333 |
Related Headline
Stoke Therapeutics Headline on 17th of March 2023
Filed transaction by Stoke Therapeutics Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
SpringWorks Therapeutics Valuation on March 17, 2023
It is possible to determine the worth of SpringWorks Therapeutics on a given historical date. On March 17, 2023 SpringWorks was worth 29.55 at the beginning of the trading date compared to the closed value of 29.03. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of SpringWorks Therapeutics stock. Still, in general, we apply an absolute valuation method to find SpringWorks Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of SpringWorks Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against SpringWorks Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 31.45 | 31.45 | 29.43 | 29.85 | 1,192,912 | |
03/17/2023 | 29.55 | 30.13 | 28.96 | 29.03 | 1,919,660 |
| 29.20 | 29.61 | 28.54 | 29.18 | 536,000 |
| Backtest SpringWorks Therapeutics | | | SpringWorks Therapeutics History | | | SpringWorks Therapeutics Valuation | Previous | Next |
SpringWorks Therapeutics Trading Date Momentum on March 17, 2023
| On March 20 2023 SpringWorks Therapeutics was traded for 29.18 at the closing time. The top price for the day was 29.61 and the lowest listed price was 28.54 . The trading volume for the day was 536 K. The trading history from March 20, 2023 was a factor to the next trading day price jump. The trading price change against the next closing price was 0.52% . The trading price change against the current closing price is 14.26% . |
SpringWorks Therapeutics Fundamentals Correlations and Trends
By evaluating SpringWorks Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among SpringWorks Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. SpringWorks financial account trend analysis is a perfect complement when working with valuation or volatility modules.About SpringWorks Therapeutics Stock history
SpringWorks Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for SpringWorks is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in SpringWorks Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing SpringWorks Therapeutics stock prices may prove useful in developing a viable investing in SpringWorks Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 63.1 M | 49.5 M | |
| Net Loss | -249.7 M | -237.2 M |
SpringWorks Therapeutics Quarterly Net Working Capital |
|
SpringWorks Therapeutics Stock Technical Analysis
SpringWorks Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
SpringWorks Therapeutics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
SpringWorks Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
SpringWorks Therapeutics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how SpringWorks Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading SpringWorks Therapeutics shares will generate the highest return on investment. By undertsting and applying SpringWorks Therapeutics stock market strength indicators, traders can identify SpringWorks Therapeutics entry and exit signals to maximize returns
SpringWorks Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for SpringWorks Therapeutics' price direction in advance. Along with the technical and fundamental analysis of SpringWorks Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of SpringWorks to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0209 | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.44) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0491 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for SpringWorks Stock Analysis
When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.